viernes, 31 de octubre de 2025

Novo Nordisk makes offer for obesity-focused Metsera, aiming to outbid Pfizer The rival proposals reflect how competitive and crucial the obesity market has become for pharma companies

https://www.statnews.com/2025/10/30/novo-nordisk-metsera-pfizer-acquisition-offer-bidding-war/

No hay comentarios: